No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in ...

Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide ...

In commodities, Brent crude climbed 0.5% to $64.95 a barrel, and WTI crude rose 0.7% to $62.93 a barrel. The European benchmark price for natural gas, the Dutch futures contract TTF, was up 0.2% to 35 ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market. For the second time ...

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its tally of weight-loss candidates in clinical development to five.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Bank of ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Cimzia® is a registered trademark of UCB Pharma S.A.

Suven Life Sciences shares have surged 98.3% from ₹120 to ₹238 over 22 trading sessions, driven by a recent ₹857 crore ...